International Biotechnology Trust plc reported earnings results for the half year ended February 28, 2023. For the half year, the company reported net income was GBP 16.96 million compared to net loss of GBP 48.63 million a year ago. Basic earnings per share from continuing operations was GBP 0.4157 compared to basic loss per share from continuing operations of GBP 1.1795 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
702 GBX | +0.29% |
|
+9.35% | +9.35% |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.35% | 338M | |
+10.99% | 15.43B | |
+6.86% | 6.69B | |
+32.18% | 5.31B | |
+10.43% | 4.49B | |
-8.05% | 4.13B | |
+14.31% | 3.65B | |
+0.96% | 3.57B | |
+12.05% | 3.24B | |
+18.53% | 3.04B |
- Stock Market
- Equities
- IBT Stock
- News International Biotechnology Trust plc
- International Biotechnology Trust plc Reports Earnings Results for the Half Year Ended February 28, 2023